Academic freedom in clinical research

被引：56

作者：

Nathan, DG ^{[1
]}

Weatherall, DJ

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Univ Oxford, Oxford OX3 9DS, England

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 347卷 / 17期

关键词：

D O I：

10.1056/NEJMsb020394

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1368 / 1371

页数：4

相关论文

共 30 条

[1] [Anonymous], 2001, NATURE, V409, P119
[2] TOXICITY OF ORAL IRON CHELATOR L1
BERDOUKAS, V
BENTLEY, P
FROST, H
SCHNEBLI, HP
[J]. LANCET, 1993, 341 (8852) : 1088 - 1088
[3] EFFICACY OF DEFEROXAMINE IN PREVENTING COMPLICATIONS OF IRON OVERLOAD IN PATIENTS WITH THALASSEMIA MAJOR
BRITTENHAM, GM
GRIFFITH, PM
NIENHUIS, AW
MCLAREN, CE
YOUNG, NS
TUCKER, EE
ALLEN, CJ
FARRELL, DE
HARRIS, JW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (09) : 567 - 573
[4] CHOUDHURY R, 1995, DRUG METAB DISPOS, V23, P314
[5] CRANTON J, 2001, COMMUNICATION 1219
[6] Davidoff F, 1999, ANN INTERN MED, V130, P246
[7] Sponsorship, authorship, and accountability.
Davidoff, F
DeAngelis, CD
Drazen, JM
Hoey, J
Hojgaard, L
Horton, R
Kotzin, S
Nicholls, MG
Nylenna, M
Overbeke, AJPM
Sox, HC
Van Der Weyden, MB
Wilkes, MS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) : 825 - 827
[8] Factors influencing effectiveness of deferiprone in a thalassaemia major clinical setting
Del Vecchio, GC
Crollo, E
Schettini, F
Schettini, F
Fischer, R
De Mattia, D
[J]. ACTA HAEMATOLOGICA, 2000, 104 (2-3) : 99 - 102
[9] HIDER RC, 1990, ANN NY ACAD SCI, V612, P327
[10] Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients
Hoffbrand, AV
Al-Refaie, F
Davis, B
Siritanakatkul, N
Jackson, BFA
Cochrane, J
Prescott, E
Wonke, B
[J]. BLOOD, 1998, 91 (01) : 295 - 300